| The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells CT Zumbar, A Usubalieva, PD King, X Li, CS Mifsud, HM Dalton, M Sak, ... Journal of Neuro-oncology 137, 481-492, 2018 | 23 | 2018 |
| Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells M Sak, CT Zumbar, PD King, X Li, CS Mifsud, A Usubalieva, CD Anderson, ... Journal of Neuro-oncology 143, 231-240, 2019 | 11 | 2019 |
| Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes NL Lehman, N Spassky, M Sak, A Webb, CT Zumbar, A Usubalieva, ... Nature Communications 13 (1), 2083, 2022 | 9 | 2022 |
| The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo M Sak, BJ Williams, CT Zumbar, L Teer, MNG Al-Kawaaz, A Kakar, ... Cancer Chemotherapy and Pharmacology 91 (2), 191-201, 2023 | 4 | 2023 |
| Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutations M Terry, K Wakeman, BJ Williams, DM Miller, M Sak, Z Abdullaev, ... Free Neuropathology 3, 2022 | 4 | 2022 |
| Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes NL Lehman, N Spassky, M Sak, A Webb, CT Zumbar, A Usubalieva, ... nature communications 14, 2023 | 2 | 2023 |
| Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms KJ Alkhateeb, JE Crane, M Sak, CJ Jorgensen, JP O’Donnell, CT Zumbar, ... Diagnostic Pathology 16, 1-8, 2021 | 2 | 2021 |
| EXTH-22. The CNS penetrating taxane TPI 287 and the aurka inhibitor alisertib improve survival in vivo B Williams, C Zumbar, M Sak, N Lehman Neuro-Oncology 22 (Suppl 2), ii91, 2020 | 2 | 2020 |
| EXTH-75. The aurora kinase A inhibitor alisertib is synergistic with irinotecan and carboplatin against glioblastoma cells E Burton, C Zumbar, P King, M Sak, A Usubalieva, X Li, C Mifsud, ... Neuro-Oncology 20 (Suppl 6), vi101, 2018 | 1 | 2018 |
| Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis study M Sak, JH Chariker, JW Park, EC Rouchka medRxiv, 2024 | | 2024 |
| Aurka inhibition-based combination therapy approaches in glioblastoma. M Sak | | 2023 |
| EXTH-46. ALISERTIB POTENTIATES THE EFFECT OF CABOZANTINIB AND VANDETANIB AGAINST GLIOBLASTOMA CELLS B Williams, C Zumbar, C Mifsud, K Smith, M Sak, N Lehman Neuro-Oncology 21 (Suppl 6), vi92, 2019 | | 2019 |
| The AURKA Inhibitor Alisertib Is Synergistic With Irinotecan And Carboplatin Against Glioblastoma Cells C Zumbar, P King, M Sak, A Usubalieva, X Li, C Mifsud, J McElroy, ... JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 77 (6), 491-492, 2018 | | 2018 |
